Analysis from a Columbia and Rutgers Health team finds long-term antipsychotic use rose 65% from 2015 to 2024.

Harrow, Inc. (NASDAQ: HROW), a U.S.-based provider of ophthalmic disease management solutions, announced on Friday that it has agreed to acquire Melt Pharmaceuticals, Inc., a clinical-stage company ...

Sedatives frequently prescribed to Alzheimer’s patients may increase those patients’ risk of contracting pneumonia, according to a new study published in the Canadian Medical Association Journal. Both ...

Once rampant in Philly's drug supply, xylazine is now on the decline after a statewide crackdown, experts tell Axios. Why it matters: The drug, known on the streets as "tranq," is being replaced by a ...